课题基金 / 基金详情

AIRWAY MORPHOLOGY IN IL 11 OVEREXPRESSION TRANSGENIC MICE

AIRWAY MORPHOLOGY IN IL 11 OVEREXPRESSION TRANSGENIC MICE
IL 11 过度表达转基因小鼠的气道形态
批准号:
6282347
负责人:
JACK A ELIAS
金额:
$1.33万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
已结题
起止时间:
1998-09-30 至 1999-08-31

项目摘要

项目成果

JACK A ELIAS的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The asthmatic diathesis is characterized by chronic airway inflammation. In vivo and in vitro studies have demonstrated the disregulation of a wide variety of cytokines in the asthmatic airway. However, in most circumstances, the ability of individual cytokines to mediate the pathologic and physiologic derangements characteristic of this disorder are poorly understood. to address this issue, we have developed a system that allows us to express cytokines in the murine airway in an organ-specific fashion. When this was done with human interleukin-11, prominent abnormalities were noted. They included: a) peribronchiolar nodular inflammatory infiltrates, b) subepithelial fibrosis with airway remodeling; c) emphysema in alveolar areas; and d) airways hyper-responsiveness to methacholine. To further understand the morphology of the airways of these mice, we propose to use the Center for In Vivo Microscopy to characterize the airways of transgene (+) and transgene (-) animals. It is hoped that this approach will enable us to differentiate remodeling from hypoplasia. The effects of other cytokines on airway development and structure will be analyzed in a similar fashion.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
AIRWAY MORPHOLOGY IN IL 11 OVEREXPRESSION TRANSGENIC MICE
  • 批准号:
    6122312
  • 项目类别:
  • 资助金额:
    $0.05万
  • 财政年份:
    1999
  • 负责人:
    JACK A ELIAS
  • 依托单位:
AIRWAY MORPHOLOGY IN IL 11 OVEREXPRESSION TRANSGENIC MICE
  • 批准号:
    6253341
  • 项目类别:
  • 资助金额:
    $0.75万
  • 财政年份:
    1997
  • 负责人:
    JACK A ELIAS
  • 依托单位:
AIRWAY MORPHOLOGY IN IL 11 OVEREXPRESSION TRANSGENIC MICE
  • 批准号:
    5225135
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    --
  • 负责人:
    JACK A ELIAS
  • 依托单位:
    --
海外基金